tobrex 2x silmatilgad, lahus
novartis baltics sia - tobramütsiin - silmatilgad, lahus - 3mg 1ml 5ml 1tk
tobrex silmasalv
novartis baltics sia - tobramütsiin - silmasalv - 3mg 1g 3.5g 1tk
ciloxan silmatilgad, lahus
novartis baltics sia - tsiprofloksatsiin - silmatilgad, lahus - 3mg 1ml 5ml 1tk
zofran õhukese polümeerikattega tablett
novartis baltics sia - ondansetroon - õhukese polümeerikattega tablett - 8mg 10tk
tobradex silmatilgad, suspensioon
novartis baltics sia - deksametasoon+tobramütsiin - silmatilgad, suspensioon - 1mg+3mg 1ml 5ml 1tk
ciprobay hc kõrvatilgad, suspensioon
novartis baltics sia - hüdrokortisoon+tsiprofloksatsiin - kõrvatilgad, suspensioon - 10mg+2mg 1ml 10ml 1tk
locametz
novartis europharm limited - gozetotide - radionukliidi pildistamine - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
premier klercide-cr sterile biocide b spray novartis
ecolab deutschland gmbh -
femara õhukese polümeerikattega tablett
novartis baltics sia - letrosool - õhukese polümeerikattega tablett - 2,5mg 28tk; 2,5mg 10tk; 2,5mg 100tk
diovan õhukese polümeerikattega tablett
novartis baltics sia - valsartaan - õhukese polümeerikattega tablett - 40mg 90tk; 40mg 280tk; 40mg 30tk; 40mg 98tk; 40mg 56tk; 40mg 28tk; 40mg 7tk